Skip to content

Evaluation of the Efficiency of Two-Incision, Wire-Assisted Achilles Tendon Z-Lengthening for Achilles Tendon Contructure: a Prospective Randomized Controlled Clinical Trial

Evaluation of the Efficiency of Two-Incision, Wire-Assisted Achilles Tendon Z-Lengthening for Achilles Tendon Contructure: a Prospective Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036194
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achilles Tendon Contracture

Interventions

Experimental group:Two-Incision, Wire-Assisted Achilles Tendon Z-Lengthening
Control group:Z-plasty Achilles Tendon Lengthening

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Medical history:Achilles tendon contracture caused by systemic or peripheral lesions, affecting daily life such as heel lifting and walking; 2.Clinical symtoms:affective foot heel landing when walking,middle and front dorsal extension limited,difficult to climb stairs,severe walking lameness; 3.Physical examination:limited ankle joint active and passive dorsiflexion, increased Achilles tendon tension during dorsiflexion, with or without mild foot internus and valgus deformity; 4.6 weeks of functional exercise or other conservative treatment failed; 5.Willing to undergo surgery; 6.Willing to cooperate with the investigation and follow-up and sign the informed consent

Exclusion criteria

Exclusion criteria: 1.Atrophy of Achilles tendon, gastrocnemius muscle and soleus muscle due to central lesion or peripheral neuropathy; 2.Infection in Achilles tendon lengthening area; 3.Patients with other systemic diseases that cannot tolerate surgery.

Design outcomes

Primary

MeasureTime frame
12 months and 24 months validity;

Secondary

MeasureTime frame
AOFAS score;Kofoed;EQ-5D-3L;MRI;VAS;

Countries

China

Contacts

Public ContactDajiang Du

Shanghai Sixth People's Hospital

dudajiang@sjtu.edu.cn+8618930174817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026